The Latest Breaking News from Canaccord

That would represent a record annual sum posted by any Scottish football club and shares in the Hoops have subsequently increased.

Millionaire banker Stephen Massey has taken over the running of the Conservative Party's local election campaign. His City firm warned Britain is facing 'insipid growth' under this government

MicroStrategy (NYSE: MSTR) recently reported a net loss of more than $1 billion in the second quarter compared with a loss of about $299.3 million in the same period last year.

Plummeting cryptocurrency prices have made life difficult for Bitcoin (CRYPTO: BTC) miners in 2022, but Canaccord Genuity analyst Joseph Vafi said Monday that he maintains his bullish long-term outlook for crypto miners Argo Blockchain ADR (NASDAQ:

AutoCanada Inc. (TSX:ACQ) (OTC:AOCIF) was downgraded to Sector Perform from Outperform, and the price target was lowered to C$37 from C$52 by National Bank analyst Maxim Sytchev. The analyst believes that AutoCanada's management continues to execute well, but the shares will have a challenge recapturing the prior highs amid higher inflation. Recently, Canaccord analyst Luke Hannan has…

BMO Capital analyst Rene Cartier raised the price target for Altius Minerals Corp  (TSX:ALS) (OTC:ATUSF) to C$23 from C$22 while maintaining the Market Perform rating on the shares. The target price was increased as the analyst raised multiples to align more closely with royalty/streaming peers. The analyst states that ALS delivered slightly better-than-expected 1Q22 attributable…

Gran Tierra Energy Inc (TSX:GTE) (NYSE:GTE) coverage has been initiated by Canaccord analyst Roman Rossi, with a Buy rating and a price target of C$2.70. According to Rossi, Gran Tierra is a very interesting play in an investor-friendly jurisdiction. The stock could be primed for more growth as the drilling campaign progresses, despite the…

Analysts mainly slashed the price targets or downgraded the rating on Blend Labs Inc (NYSE:BLND) post Q4 results. KeyBanc analyst Josh Beck lowered the price target to $6 from $10 (26% upside) and kept an Overweight.  The company's FY22 revenue forecast was well below the Street's $343.8 million, reflecting the negative impact of higher rates…

Analysts painted a sharp upside to CrowdStrike Holdings Inc (NASDAQ:CRWD) after it reported a stronger than expected Q4 and initial FY23 growth outlook. ARR rose 65% Y/Y and grew to $1.73 billion, of which $216.9 million was net new ARR added in Q4. BTIG analyst Gray Powell upgraded to Buy from Neutral with a $257 PT (51.4%…

Natera Inc (NASDAQ: NTRA) analyst Kyle Mikson of Canaccord Genuity Capital reiterated a Buy rating Wednesday on the genetic testing company  following a Hindenburg Research short 

Piper Sandler has downgraded Vicarious Surgical Inc (NASDAQ:RBOT) to Neutral from Overweight with a price target of $7, down from $16, below expected Q4 results.  A majority of the earnings call focused on the Company's regulatory update. Vicarious announced its plans to pursue a De Novo FDA pathway, including a pre-market study, for its…